With 2015 winding to a close, it is the time of year to begin looking at your investment options for 2016. Good financial health is dependent on planning and opportunity, both of which you will need for your investment portfolio in the new year. Working with your broker can give you a clue on where your money-making opportunities lie, but a little personal research won’t hurt either. Included here are a few of the best investments for 2016.
The technological advances making strides in the entertainment business are evident in IMAX theaters more than anywhere else. With IMAX’s second quarter of 2015 grossing 35% increase, this is definitely a stock to watch. Earnings on IMAX shares were reported as high as $0.40, up from $0.25 the same time in 2014.
Physicians Realty Trust
Physicians Realty Trust, (DOC), is a real estate company that owns and manages healthcare properties like clinics and hospitals. The portfolio of properties owned by DOC was 94.6% leased out in June of 2015. With a dividend yield of 6.2%, DOC is showing a great deal of growth for a small company and has stocks selling below $17.
If you utilize the services provided by email, Google, or Facebook, you are using a cloud-based system. With the need for greater storage capacities provided by cloud, companies like Arista, or ANET stocks, will be on the rise. ANET uses the less-conventional Linnux-based operating system to run its Extensible Operating System. Arista earnings boosted from $0.35 in 2014 to $0.54 per share in 2015 and are forecast to rise again.
The leading international provider of community reentry, detention and corrections services, GEO promises growth around the globe. GEO is reporting a dividend yield of 8%, but is considered a high-risk stock for long-term investors due to its volatility in relation to politics and social climate. Buy stocks for GEO at $34.50 or less.
Orchids Paper Products
Consistently putting out great performance in the staples industry, Orchids produces hygienic tissue products primarily sold in dollar stores. Although Orchids is small, it is reliable with its consistent growth and profit in the market. Orchids offers a high yield dividend of 5.7% and $0.35 per quarter. While growth has been slow in the last quarter, forecasters predict Orchids is still on the rise.
A generic drugmaker, Lannett grew 42% in June earnings up to $0.91 per share; this topped predictions by $0.05. LCI has improved sales by 12% and grown profit margins for 14 consecutive quarters. With promises of growth of 4-7% in early 2016, LCI might be the stock to buy.